238 results about "Visceral fat" patented technology

The present invention is directed to novel compositions and their application as pharmaceuticals for the treatment of disease. Methods of upregulation of GLUT4 via activation of peroxisome proliferator activated receptor delta activity in the adipose tissue of a human or animal subject are also provided, for the treatment of conditions such as diabetes, obesity, insulin resistance, metabolic syndrome, and others in which a reduction in insulin resistance, an increase in glucose utilization, a reduction in visceral fat, a reduction in triglyceride (TG) levels, or an increase in levels of high-density lipoprotein (HDL), is beneficial.

The oil or fat composition of the invention contains a monoacylglycerol and / or a diacylglycerol in a total amount of 5-100 wt. % and which exhibits an index of stability against oxidation (induction time as measured through a Rancimat test conducted at 100° C.) of 7 or higher, wherein the monoacylglycerol and / or the diacylglycerol contain, as fatty acid constituents, ω3 unsaturated fatty acids in amounts of 15-90 wt. %. Through ingestion thereof in a small amount without drastically changing the person's lifestyle, the highly harmless oil / fat composition of the present invention provides effects for reducing and preventing accumulation of body fat, for reducing and preventing accumulation of visceral fat, and for prevention and treatment of obesity; and exerts an excellent prevention and treatment effect on life-style related diseases through long-term ingestion. Thus, the composition of the present invention is useful for foods, pharmaceuticals and pet food or feed.

A visceral fat determining device which is easy to operate at home and capable of providing information associated with visceral fat of a subject is disclosed. The visceral fat determining device is comprising means for inputting personal data representing vital characteristics of the subject, a data processing unit that can process various types of calculations, and a display portion capable of displaying the personal data and the calculation results. Quantitative information on the visceral fat of the subject can be obtained through the calculation based on the abdominal girth of the subject, which is a circumferential length of a torso of the subject.

Provided is an herbal extract-based composition comprising an extract of Gynostemma pentaphyllum, an extract of Crataegus pinnatifidia (hawthorn), an extract of Camellia sinensis (green tea), and an extract of Momordica charantia (bitter melon). The composition may further comprise an extract of mulberry (Morus species). Also provided is a process for preparing a herbal extract-based composition which comprises separately extracting each of hawthorn, green tea, Gynostemma pentaphyllum, mulberry, and bitter melon; drying extraction eluates obtained from the extracting of each of the herbal components to obtain organic residues in forming a hawthorn extract powder, green tea extract powder, a Gynostemma pentaphyllum extract powder, a mulberry extract powder, and a bitter melon powder; and combining the green tea extract powder, the Gynostemma Pentaphyllum extract powder, the hawthorn extract powder, the mulberry extract powder, and the bitter melon powder in desired proportions to form the herbal extract-based composition which, when taken orally, has health-promoting effects including anti-diabetic effects that include, but are not limited to, decreasing visceral fat, reducing hyperglycemia, and reducing the occurrence and severity of diabetic complications, associated with type 2 diabetes.

A CPU (134) of a body composition measuring apparatus (100) drives a navel position indicator (118) so that it emits light. The height of a frame (114) is adjusted so that a beam of light from navel position indicator (118) irradiates the navel of a human subject. Plural sensors (106) are mounted on the frame (114), and each sensor measures a distance from the sensor to a position to be measured, whereby the abdominal width (X) of the human subject is determined. Subsequently, CPU (134) obtains measured values of weight (W) and bioelectrical impedance (Z). CPU (134) then reads an equation for calculating the visceral fat area and estimates the visceral fat area (Y) based on the measured abdominal width (X), weight (W), bioelectrical impedance (Z), and the equation.

A visceral fat measurement device includes a first electrode pair and a second electrode pair to be arranged in a body axis direction at a back surface of an abdomen of a subject; a current generation unit for flowing current between electrodes of the first electrode pair; a potential difference detection unit for detecting a potential difference between electrodes of the second electrode pair current is flowed between the electrodes of the first electrode pair; and a visceral fat mass calculation part for calculating visceral fat mass of the subject based on the detected potential difference between the electrodes of the second electrode pair.

In a body fat measuring apparatus, a constant electric-current is flowed between hand electric-current electrodes and leg electric-current electrodes. From two detected voltages generated between an annular-shaped voltage electrode placed on an abdominal portion and two voltage electrodes placed at the both sides of a lumbar portion, two abdominal impedances are determined. Two electric-current electrodes and two voltage electrodes are placed such that they are spaced apart by a small interval from one another at an umbilicus portion. A constant electric current is flowed between the two electric-current electrodes and the impedance in the vicinity of the subcutaneous of the abdominal portion is determined from the detected voltage generated between the two voltage electrodes. From the two abdominal impedances, the impedance in the vicinity of the subcutaneous of the abdominal portion, and the input physique information, a viscera impedance is calculated.

To accurately acquire body composition information using data acquired by another device. Thus, there is provided a body composition monitor with scale including a communication unit for allowing input of biological component information (cross-sectional area, site length, subcutaneous fat percentage, visceral fat percentage, etc.) of a living body measured with another device such as an MRI, where step of calculating the body composition of the living body based on the biological component information, an impedance detected by an impedance detection unit, and a weight measured by a load detection unit is executed.

Disclosed are methods and compositions for treating visceral fat conditions and / or metabolic syndrome using combinations of naltrexone and bupropion.

Methods and apparatus for measuring visceral fat mass are provided. One method includes acquiring dual-energy two-dimensional (2D) scan information from a dual-energy x-ray scan of a body and generating a dual-energy image of the body using the 2D scan information. The method further includes identifying a region of interest using the dual-energy image and determining a subcutaneous fat mass for each of a plurality of sections of the region of interest. The method also includes determining a visceral fat mass for the region of interest based on the determined subcutaneous fat mass for each of the plurality of sections.

A device for the treatment of pathologies related to accumulation of visceral fat and for the treatment of EFP in all its stages, comprising ‘clever’ handles for generation of acoustic waves, vacuum-assisted suction and cooling.

The invention discloses a dietetic food composition for losing weight. The composition comprises the following ingredients: fresh meat and aquatic product, vegetables, fruits, dried mushroom products, cereals, beans, nut meat, edible vegetable oil, eggs, protein hydrolysate powder, dietary fiber powder, konjac powder, guar gum, polyols, phosphatidylcholine, fruit polyphenols, L-carnitine, vitamin A, vitamin E, vitamin C, thiamine hydrochloride, riboflavin, nicotinamide, pyridoxine hydrochloride, folic acid, cyanide-containing cobalt and pantothenic acid. By adopting the dietetic food composition disclosed by the invention, the total energy intake is reduced under the premise of ensuring normal basic metabolic rate, the requirements of the body on protein at a low-energy diet period are improved, and related nutrients are replenished to facilitate body fat, visceral fat and blood lipid metabolism, so as to achieve the target of losing weight. Meanwhile, the invention also discloses a preparation method of the dietetic food composition and use of the dietetic food composition in preparation of a medicament for preventing or treating an obesity disease.

Disclosed is an apparatus for assuming the information on the amount accumulated visceral fat in a human body with a high degree of accuracy. It comprises: at least a unit for collecting pieces of information on the identification of the human body and a unit for collecting pieces of information on breathing function, thereby making the visceral fat accumulation calculating unit provide the information on the amount accumulated visceral fat based on the so collected pieces of information.

Dual-energy absorptiometry is used to estimate visceral fat metrics and display results, preferably as related to normative data. The process involves deriving x-ray measurements for respective pixel positions related to a two-dimensional projection image of a body slice containing visceral fat as well as subcutaneous fat, at least some of the measurements being dual-energy x-ray measurements, processing the measurements to derive estimates of metrics related to the visceral fat in the slice, and using the resulting estimates. Processing the measurements includes an algorithm which places boundaries of regions, e.g., a large “abdominal” region and a smaller “abdominal cavity” region. Two boundaries of the “abdominal cavity” region are placed at positions associated with the left and right innermost extent of the abdominal muscle wall by identifying inflection of % Fat values. The regions are combined in an equation that is highly correlated with VAT measured by quantitative computed tomography in order to estimate VAT.

A method and apparatus capable of measuring visceral fat tissues accumulated in the trunk with high accuracy apply a current to a body part where a subcutaneous fat tissue layer is thin or a body part where a skeletal muscle tissue layer has no or a thin muscle belly portion from a pair of current applying electrodes, measure a potential difference which has occurred in the tissue through which the current has passed by a pair of voltage measuring electrodes, and determine the visceral fat tissue volume of the trunk by use of the impedance of the trunk which has been obtained by use of the measured potential difference.

A body fat measuring apparatus includes: an upper limb unit including a hold portion that can be held in a hand of a subject and a main portion; and a lower limb electrode to be contacted with a lower limb of the subject. The hold portion includes an upper limb electrode, and the main portion includes a first surface to be contacted with a surface of an abdomen of the subject as well as a pair of first electrodes and a pair of second electrodes arranged at the first surface. The body fat measuring apparatus calculates a visceral fat amount of the subject based on two types of potential differences that are detected respectively in a case where an electric current is applied via a pair of the upper and lower limb electrodes and a case where an electric current is applied via the pair of second electrodes as well as physical data of the subject.

PCT No. PCT / JP97 / 04051 Sec. 371 Date May 6, 1999 Sec. 102(e) Date May 6, 1999 PCT Filed Nov. 7, 1997 PCT Pub. No. WO98 / 20871 PCT Pub. Date May 22, 1998Methods for decreasing visceral fat, inhibiting accumulation of visceral fat and improving the distribution of visceral fat all include the administration of a thiazolidine derivative represented by formula (IV), wherein A3 represents an optionally substituted phenyl or oxazolyl group.

Embodiments of systems, kits, and methods to perform transgastric procedures to removing visceral fat in the peritoneal cavity are described. Am embodiment includes deliberately breaching a wall of a gastrointestinal tract to enter the peritoneal cavity to physically remove visceral fat adjacent or on outer surfaces of organs located within the peritoneal cavity. A user can identify regions of visceral fat desired to be removed. A user can insert an instrument through the mouth into the stomach of the patient. The user makes an incision in the wall of the organ adjacent the visceral fat to be removed. Using visual guidance for the instrument, the user passes a distal end of the instrument through an opening formed by the incision into the peritoneal cavity. A user utilizes removes the visceral fat from outer surfaces of the organ, the opening is closed, and the tool is removed from the patient.

The invention discloses an electronic scale system with a wireless transmission function. The electronic scale system with the wireless transmission function is characterized by comprising a weighing unit, a cloud part and a mobile terminal, wherein the weighing unit serves as a scale body and comprises a main control panel, a wireless communication module, a display screen, a power source, buttons, a BIA detecting unit and a weighing sensor, the wireless communication module, the display screen, the power source, the buttons, the BIA detecting unit and the weighing sensor are respectively connected with the main control panel, an electrode plate is connected on the BIA detecting unit, a stress mechanism is connected on the weighing sensor, the cloud part comprises a cloud server and a wireless access point connected with the cloud server, the weighing unit is provided with an independent internet protocol (IP) which is used for being identified by the cloud part and the mobile terminal, the scale body can measure the weight, fat percentage, water percentage, muscle percentage, human-body bone content, visceral fat percentage or body mass index (BMI) value of a human body, the data can be transmitted by the wireless communication module, and the data are received by the wireless access point of the cloud part. Management software is arranged inside the cloud server, independent management files are established as each IP is independently matched with the scale body, and the data are stored. A terminal account can receive data of the scale body with the corresponding IP from the cloud part through a server.

A visceral fat scale equipped with a sphygmomanometer is described, with which a subject can keep track of blood pressure values and grasp the state of obesity to attain more accurate, comprehensive and diversified diagnoses and disease prevention. The visceral fat scale is designed such that after exerting pressure to an artery of a subject by inflation of a cuff, a pulse wave signal is detected in the course of gradual cuff deflation and blood pressure is obtained based on the detected pulse wave signal. The scale comprises an increment / decrement key and display mode selector key for inputting personal data of the subject; an arithmetic operation unit for calculating the amount of visceral fat of the subject based on data input by these keys; and a display unit for displaying a result of the calculation performed by the arithmetic operation unit.

Disclosed is a visceral fat estimation apparatus, comprising: an input device: an estimation device; a target calorie intake determination device; a calorie consumption determination device; an allowable calorie intake update device; and a calorie consumption device. According to the present invention the input device enters at least height, body weight and body fat rate of a person to be measured, and the estimation device estimates a visceral fat area based in the input value entered by the input device. Furthermore, the target calorie intake determination device determines a target calorie intake for a day, and the calorie consumption determination device determines a calorie to be consumed due to an exercise for a day. The allowable calorie intake update device updates an allowable calorie intake for a day, and the calorie consumption update device updates a calorie to be consumed due to an exercise for a day.

A medical device having an impedance measurement circuit connected to at least two intracorporeal measurement electrodes arranged to measure the impedance of tissue inside the body of a patient. The impedance measurement circuit is adapted to apply a measurement current / voltage signal to the electrodes to measure and calculate the impedance of the measurement tissue, and to apply the calculated impedance value to a storage unit. The stored impedance values are used, by an analysis unit, to measure the amount of visceral fat of the tissue object inside the body of the patient.

A nutritional composition is provided which has an effective prophylactic and / or improving effect for various symptoms of muscle mass decrease, decreased basal metabolism, low body temperature, suppression of obesity, suppression of visceral fat accumulation, hyperglycemia, hyperlipidemia and the like in elderly people. The nutritional composition can include n-3 fatty acid and one or more of free lysine, dipeptides containing lysine, and lysine salts, wherein the content of free lysine, dipeptides containing lysine, and / or lysine salts is 0.1 g-10.0 g per 100 kcal of the composition, and the content of the total amount of n-3 fatty acid is 0.17 g-5.00 g per 100 kcal of the composition.

The present invention provides methods and compositions for reducing visceral fat by administering to the subject a therapeutically effective amount of a compound that increases the bioactive serum levels of insulin-like growth factor-1 (IGF-1) in the subject, thereby ameliorating negative effects of visceral obesity. The invention is useful in the treatment, prevention, or amelioration of one or more symptoms of visceral obesity or IGF-1 deficiency related condition, including, for example, cardiovascular disease and the metabolic syndrome.

Provided is an oil / fat composition comprising 10.1 to 94.9 wt. % of a triglyceride, 0.1 to 30 wt. % of a monoglyceride and 5 to 59.9 wt. % of a diglyceride which has, as a fatty acid constituent thereof, 15 to 90 wt. % of an ω3-unsaturated fatty acid having less than 20 carbon atoms. The oil / fat composition of the present invention has excellent heat stability, has body-fat-accumulation resisting action, visceral-fat-accumulation resisting action, blood-sugar-level lowering action, insulin resistance improving action and leptin lowering action and is useful for, as well as pharmaceuticals, preventive or remedial food for diabetes or obesity, and feed.

Disclosed is an agent for reducing visceral fat, which comprises a cell of a lactic acid bacterium, particularly a lactic acid bacterium belonging to the genus Lactobacillus or Lactococcus and / or a culture of the cell as an active ingredient. The agent can ameliorate the disease condition of metabolic syndrome which is a combination of risk factors including hypertension, hyperlipemia, impaired glucose tolerance and the like, and can also reduce the accumulation of visceral fat. Further disclosed is a food / beverage or feed comprising the agent.

Abstract Provided is an oil / fat composition comprising 60 to 100 wt. % of a diglyceride wherein the diglyceride has, as the fatty acid constituent thereof, 15 to 90 wt. % of an ω 3-unsaturated fatty acid having less than 20 carbon atoms and a cis ω 3-unsaturated fatty acid / (cis ω 6-unsaturated fatty acid+saturated fatty acid+trans unsaturated fatty acid) at a weight ratio of 1 to 6. The composition is excellent in visceral fat burning property, body fat burning property and stability against autoxidation.